Company

Santen Pharmaceutical Co. Ltd

Headquarters: Osaka, Japan

Employees: 4,229

CEO: Mr. Shigeo Taniuchi

JPX: 4536 -0.42%

Market Cap

¥607.93 Billion

JPY as of July 1, 2024

US$3.77 Billion

Market Cap History

Santen Pharmaceutical Co. Ltd market capitalization over time

Evolution of Santen Pharmaceutical Co. Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Santen Pharmaceutical Co. Ltd

Detailed Description

Santen Pharmaceutical Co., Ltd. researches and develops, manufactures, and markets pharmaceuticals and medical devices in Japan and internationally. It offers various pharmaceutical products to treat glaucoma and ocular hypertension, such as DE-111, which is in Phase III clinical trial; DE-117 in Japan; DE-126 that is in Phase IIb clinical trial; DE-128 in Europe, as well as is in Phase II/III clinical trial in the United States; and DE-130A that is in Phase III clinical trial. In addition, the company provides DE-114A to treat allergic conjunctivitis; DE-076C for the treatment of vernal keratoconjunctivitis; and DE-109, which is in Phase III clinical trial to treat uveitis. Further, it offers DE-127 to treat myopia, which is in Phase II/III clinical trial in Japan, as well as is in Phase III in Asia; DE-089C, which has completed Phase III clinical trials for the treatment of dry eye; and STN1013400, which is in Phase I clinical trials for the treatment of myopia. Additionally, the company offers over-the-counter pharmaceutical products. The company was formerly known as Santendo Pharmaceutical Co., Ltd. and changed its name to Santen Pharmaceutical Co., Ltd. in 1958. Santen Pharmaceutical Co., Ltd. was founded in 1890 and is headquartered in Osaka, Japan.

Top 1-year algo backtest: +227.67%

$10,000 in September 2023 would now be $32,767 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Santen Pharmaceutical Co. Ltd has the following listings and related stock indices.


Stock: JPX: 4536 wb_incandescent

Stock: FSX: SZD wb_incandescent

Stock: OTC: SNPHF wb_incandescent

Stock: OTC: SNPHY wb_incandescent

Details

Headquarters:

Grand Front Osaka Tower A

4-20 Ofuka-cho Kita-ku

Osaka, 530-8552

Japan

Phone: 81 6 6321 7000

Fax: 81 6 6321 5082